Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II.

L-Asparaginase (isozyme II) from Escherichia coli is an important therapeutic enzyme used in the treatment of leukemia. Extracellular expression of recombinant asparaginase was obtained by fusing the gene coding for asparaginase to an efficient pelB leader sequence and an N-terminal 6x histidine tag cloned under the T7lac promoter. Media composition and the induction strategy had a major influence on the specificity and efficiency of secretion of recombinant asparaginase. Induction of the cells with 0.1 mM IPTG at late log phase of growth in TB media resulted in fourfold higher extracellular activity in comparison to growing the cells in LB media followed by induction during the mid log phase. Using an optimized expression strategy a yield of 20,950 UI/L of recombinant asparaginase was obtained from the extracellular medium. The recombinant protein was purified from the culture supernatant in a single step using Ni-NTA affinity chromatography which gave an overall yield of 95 mg/L of purified protein, with a recovery of 86%. This is approximately 8-fold higher to the previously reported data in literature. The fluorescence spectra, analytical size exclusion chromatography, and the specific activity of the purified protein were observed to be similar to the native protein which demonstrated that the protein had folded properly and was present in its active tetramer form in the culture supernatant.

[1]  G. Larsson,et al.  Cell and process design for targeting of recombinant protein into the culture medium of Escherichia coli , 2003, Applied Microbiology and Biotechnology.

[2]  J. Broome.  STUDIES ON THE MECHANISM OF TUMOR INHIBITION BY L-ASPARAGINASE , 1968, The Journal of experimental medicine.

[3]  I. Polikarpov,et al.  Stability of L-asparaginase: an enzyme used in leukemia treatment. , 1999, Pharmaceutica acta Helvetiae.

[4]  M. Jaskólski,et al.  Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Lory.  Secretion of proteins and assembly of bacterial surface organelles: shared pathways of extracellular protein targeting. , 1998, Current opinion in microbiology.

[6]  I. Holland,et al.  Protein secretion pathways in Escherichia coli , 1994 .

[7]  J. Broome.  Antilymphoma activity of L-asparaginase in vivo: clearance rates of enzyme preparations from guinea pig serum and yeast in relation to their effect on tumor growth. , 1965, Journal of the National Cancer Institute.

[8]  D. Baty,et al.  Increased efficiency of alkaline phosphatase production levels in Escherichia coli using a degenerate PelB signal sequence. , 1996, Gene.

[9]  K. Jeong,et al.  Secretory production of human leptin in Escherichia coli. , 2000, Biotechnology and bioengineering.

[10]  L. Jolliffe,et al.  Refolding, purification, and characterization of human erythropoietin binding protein produced in Escherichia coli. , 1996, Protein expression and purification.

[11]  J. H. Schwartz,et al.  Two L-asparaginases from E. coli and their action against tumors. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Yuan Zhang,et al.  Stationary phase protein overproduction is a fundamental capability of Escherichia coli. , 2004, Biochemical and biophysical research communications.

[13]  M. Reuss,et al.  Identification of factors impeding the production of a single-chain antibody fragment in Escherichia coli by comparing in vivo and in vitro expression , 2003, Applied Microbiology and Biotechnology.

[14]  C. S. Hoffman,et al.  Fusions of secreted proteins to alkaline phosphatase: an approach for studying protein secretion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Larsson,et al.  Growth rate-dependent changes in Escherichia coli membrane structure and protein leakage , 2002, Applied Microbiology and Biotechnology.

[16]  J Gumpert,et al.  Use of cell wall-less bacteria (L-forms) for efficient expression and secretion of heterologous gene products. , 1998, Current opinion in biotechnology.

[17]  P. Cornelis,et al.  Expressing genes in different Escherichia coli compartments. , 2000, Current opinion in biotechnology.

[18]  S. Shifrin,et al.  L-Asparaginase from Escherichia coli B. Physicochemical studies of the dissociation process. , 1971, The Journal of biological chemistry.

[19]  M. Basri,et al.  Secretory expression in Escherichia coli and single-step purification of a heat-stable alkaline protease. , 2003, Protein expression and purification.

[20]  M. Sowden,et al.  Increasing the yield of soluble recombinant protein expressed in E. coli by induction during late log phase. , 2003, BioTechniques.

[21]  G. Hannig,et al.  Strategies for optimizing heterologous protein expression in Escherichia coli. , 1998, Trends in biotechnology.

[22]  K. Friehs,et al.  Extracellular production of a hybrid β-glucanase from Bacillus by Escherichia coli under different cultivation conditions in shaking cultures and bioreactors , 1997, Applied Microbiology and Biotechnology.

[23]  I. Beacham,et al.  Construction of expression systems for Escherichia coli asparaginase II and two-step purification of the recombinant enzyme from periplasmic extracts. , 1991, Protein expression and purification.

[24]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[25]  Per Jonasson,et al.  Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli , 2002, Biotechnology and applied biochemistry.

[26]  H. Müller,et al.  Use of L-asparaginase in childhood ALL. , 1998, Critical reviews in oncology/hematology.

[27]  E. Holmgren,et al.  Expression and characterization of a recombinant human parathyroid hormone secreted by Escherichia coli employing the staphylococcal protein A promoter and signal sequence. , 1990, The Journal of biological chemistry.

[28]  Broome Jd.  L-Asparaginase: discovery and development as a tumor-inhibitory agent. , 1981 .

[29]  J. Cannon,et al.  Thirty-three amino acids of the mature moiety of an unprocessed maltose-binding protein are sufficient for export in Escherichia coli , 1994, Journal of bacteriology.

[30]  C. Hoischen,et al.  Expression and secretion of functional miniantibodies McPC603scFvDhlx in cell-wall-less L-form strains of Proteus mirabilis and Escherichia coli : A comparison of the synthesis capacities of L-form strains with an E. coli producer strain , 1998, Applied Microbiology and Biotechnology.

[31]  K. San,et al.  Protein Release in Recombinant Escherichia coli Using Bacteriocin Release Protein , 1992, Biotechnology progress (Print).

[32]  F. Baneyx,et al.  TolAIII co-overexpression facilitates the recovery of periplasmic recombinant proteins into the growth medium of Escherichia coli. , 1998, Protein expression and purification.

[33]  P. Denéfle,et al.  Heterologous protein export in Escherichia coli: influence of bacterial signal peptides on the export of human interleukin 1 beta. , 1989, Gene.